PATENT CLAIM ANALYSIS

Application Number: 15878396
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "468000"]

Abstract:
The present invention relates to immediate release pharmaceutical compositions comprising one or more natural or synthetic cannabinoids, and one or more pharmaceutically acceptable excipients. More specifically, the invention relates to immediate release pharmaceutical compositions comprising cannabinoids and a process for preparation thereof.

Claim (Index 15):
A drug composition comprising a monolithic matrix tablet comprising granules and extragranular excipients wherein the granules comprise:\n a. cannabidiol or THC or THCV; b. dibasic calcium phosphate; c. lactose monohydrate; d. pregelatinized modified starch; and e. hydroxyl ethyl cellulose; and\n wherein the extragranular excipients comprise: \n a. carbomer homopolymer; b. polyethylene oxide; c. hypromellose; and d. methacrylic acid copolymer.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 86.0
- Lexical Diversity: 1.53333
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15789998', '12876292', '15103850', '15554209', '14816959']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.726221023560998
- 35 USC 102 Novelty (BERT): 0.4983842597892524
- Combined Prediction Score: 0.7034373471838236
- Mean Citation Score: 241.345694
- Max Citation Score: 257.61188
- Similarity Product: 194.12912703531745

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test